Mate, I wouldnt expect big $$ in first couple of years, the...

Mate, I wouldnt expect big $$ in first couple of years, the Aussie market is just too small, there is no value in this company until a partnership is formed with a Big Pharmaceutical

Orthocells worth, as it stands is anywhere between 30 cents to 60 cents, I don’t expect this to change without a partner in the US. You can’t expect our share price to raise when as a company we are losing money quarter after quarter. Don’t underestimate another Capital Raise this year to cover costs of ATI or Remplir phase 3 trials in the States